Cryopreservation is a vital technique in biotechnology and medicine that involves preserving biological materials, such as cells, tissues, and organs, at ultra-low temperatures to maintain their viability and functionality for extended periods. This process relies on the principle of vitrification or ice-free preservation, where samples are cooled rapidly to prevent the formation of ice crystals, which can damage cellular structures and compromise viability. One of the key applications of cryopreservation is in the banking of stem cells for regenerative medicine and cell-based therapies. Stem cells, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), and adult stem cells, are cryopreserved for future use in treating a wide range of diseases and injuries, such as neurodegenerative disorders, cardiovascular diseases, and orthopaedic injuries. Cryopreservation allows for the long-term storage of stem cells while preserving their differentiation potential and therapeutic properties. In addition to stem cells, cryopreservation is used for preserving tissues and organs for transplantation. Organ cryopreservation is particularly important for overcoming the limitations of organ availability and improving transplant outcomes. By cryopreserving organs such as kidneys, livers, and hearts, it may be possible to extend the viability of donor organs and increase the pool of available organs for transplantation, ultimately saving lives and reducing waitlist times for transplant recipients.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy